Osman Moneer
Overview
Explore the profile of Osman Moneer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bourdillon A, Moneer O, Zhan K, Lee J, Valenzuela C, Farzal Z
Laryngoscope Investig Otolaryngol
. 2025 Feb;
10(1):e70103.
PMID: 39990818
Objective: Health policies affect clinical practice and outcomes, serving as an impetus for civic engagement. Voting participation among Otolaryngology-Head and Neck Surgery (OHNS) trainees is poorly characterized and may be...
2.
Mooghali M, Moneer O, Janda G, Ross J, Dhruva S, Ramachandran R
Clin Trials
. 2025 Feb;
:17407745251313979.
PMID: 39921418
Introduction: In 2005, the Centers for Medicare and Medicaid Services introduced the Coverage with Evidence Development program for items and services with limited evidence of benefit and harm for Medicare...
3.
Mooghali M, Moneer O, Janda G, Dhruva S, Ross J, Ramachandran R
Health Aff (Millwood)
. 2025 Jan;
44(1):32-39.
PMID: 39761464
The Centers for Medicare and Medicaid Services (CMS) coverage with evidence development (CED) program provides coverage for items and services not meeting Medicare's "reasonable and necessary" standard while requiring participation...
4.
Moneer O, Mooghali M, Moosa K, Ramachandran R, Ross J, Dhruva S
Health Aff (Millwood)
. 2024 Dec;
43(12):1712-1718.
PMID: 39626147
Under the 21st Century Cures Act of 2016, a summary of the evidence used to support local coverage determinations, which represent the vast majority of Medicare's coverage decisions for new...
5.
Moneer O, Johnston J, Rathi V, Ross J, Dhruva S
JAMA Health Forum
. 2024 Nov;
5(11):e244016.
PMID: 39546305
Importance: Medicare transitional pass-through payments (TPTPs) provide supplemental reimbursement that is intended to facilitate adoption of new devices in the outpatient setting. The US Centers for Medicare & Medicaid Services...
6.
Moneer O, Rathi V, Johnston J, Ross J, Dhruva S
JAMA Cardiol
. 2023 Oct;
8(12):1174-1181.
PMID: 37878306
Importance: The US Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) have different statutory authorities; FDA evaluates safety and effectiveness for market authorization of medical...
7.
Brown B, Mitra-Majumdar M, Darrow J, Moneer O, Pham C, Avorn J, et al.
JAMA Intern Med
. 2022 Oct;
PMID: 36190713
No abstract available.
8.
9.
Moneer O, Daly G, Skydel J, Nyhan K, Lurie P, Ross J, et al.
BMJ
. 2022 May;
377:e069400.
PMID: 35537738
Objective: To systematically identify, match, and compare treatment effects and study demographics from individual or meta-analysed observational studies and randomized controlled trials (RCTs) evaluating the same covid-19 treatments, comparators, and...
10.
Moneer O, Brown B, Avorn J, Darrow J, Mitra-Majumdar M, Joyce K, et al.
Drug Saf
. 2022 Feb;
45(4):305-318.
PMID: 35182362
Introduction: After the approval of a new drug, the Food and Drug Administration (FDA) may issue postmarketing requirements (PMRs), studies that the law requires manufacturers to conduct for drugs approved...